Daniel L. Spitz

13 papers receiving 494 citations

Daniel L. Spitz's Hit Papers

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study 2024 · 99 citations
990+1Years since publication255075

Peers

Daniel L. Spitz
Comparison fields: 5 of 44
  • Reproductive Medicine 162
  • Obstetrics and Gynecology 49
  • Oncology 87
  • Pulmonary and Respiratory Medicine 104
  • Complementary and alternative medicine 19
Replace Chengjuan Jin with:
Chengjuan Jin China
Gloria Mittica Italy
Kanako Inaba Japan
Ruixiu Zhang China
Ettie Piura Israel
Linjuan Xu China
K Ashihara Japan
Elena Giudice Italy
Hung-Cheng Lai Taiwan
Floriana Camarda Italy
Daniel L. Spitz relative to Chengjuan Jin China Chengjuan Jin's profile →
Citations per field
00.5×2×4×6.3×
Chengjuan Jin · 1×
Citations per year

Countries citing papers authored by Daniel L. Spitz

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Spitz more than expected).

Fields of papers citing papers by Daniel L. Spitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Spitz. The network helps show where Daniel L. Spitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel L. Spitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel L. Spitz Line = papers co-authored together Daniel L. Spitz links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 2002181
2
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
Hit paper breakdown →
202499
3 201683
4 202347
5 201339
6 201921
7 202416
8 20179
9 19886
10 20172
11 20252
12 20141
13 20141

About Daniel L. Spitz

Daniel L. Spitz is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 13 papers that have together received 507 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (3 papers), Lung Cancer Treatments and Mutations (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Cancer Genomics and Diagnostics (1 paper), Immune Cell Function and Interaction (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Reproductive Medicine (162 citations), Obstetrics and Gynecology (49 citations), Oncology (87 citations), Pulmonary and Respiratory Medicine (104 citations) and Complementary and alternative medicine (19 citations). Daniel L. Spitz has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Maurie M. Markman, SHELDON A. WEINER, James B. Hall, Linda Van Le, Linda F. Carson, John Paul Micha, Nicholas Simon Reed, Johanna C. Bendell, Gordon J.S. Rustin and Linda Duska. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, Blood and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact